A phase II study of the tolerability and activity of weekly vincristine sulfate liposomes injection (VSLI) in adults with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second relapse or progressing following two antileukemia treatment lines
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: L. T. Heffner, L. E. Damon, M. L. Larson, G. Schiller, W. Stock, H. M. Kantarjian, B. Lu, S. M. Imperiale, S. O'Brien
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2596872677
